Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Robert Henry who wrote (8380)	3/10/2000 7:00:00 PM
From: Captain Jack	Read Replies (1) \| Respond to of 9523

This looks real good-- (REUTERS) Warner-Lambert's Lipitor approved in Japan Warner-Lambert's Lipitor approved in Japan MORRIS PLAINS, N.J., March 10 (Reuters) - Warner-Lambert Co <WLA.N> said Friday its blockbuster anti-cholesterol drug, Lipitor, had received marketing approval in Japan. The New Jersey-based drugmaker said Lipitor would be co-marketed by Yamanouchi Pharmaceutical Co. Ltd. <4503.T> in Japan, the world's second-largest market for cholesterol-lowering drugs. "This approval represents an important milestone on Lipitor's path to becoming the most successful pharmaceutical product in the world," said Anthony Wild, president of Warner-Lambert pharmaceuticals. Lipitor (atorvastatin) was discovered by the Parke-Davis Research division of Warner-Lambert and has been further developed and co-marketed globally by New York-based drugmaker Pfizer Inc. <PFE.N> Pfizer on Feb. 7 agreed to buy Warner-Lambert for $90 million in stock, ending a three-month takeover battle that revolved around Lipitor. The merger would create the largest U.S. drug company and the world's No. 2 player in the highly fragmented industry. Lipitor, now available in 70 countries, had global sales of $3.7 billion in 1999. Its sales are expected to jump to $5 billion in 2000, helped in part by introduction of the potent cholesterol fighter in Japan. Warner-Lambert's stock was up 7/8 at 98-3/8 Friday afternoon in trading on the New York Stock Exchange.